American Society of Clinical Oncology (ASCO)
Jun 02, 2018 - Jun 04, 2018
2301 S King Dr.
Immune profilng of pre- and post-treatment breast cancer tissues from the SWOG S0800 randomized neoadjuvant trial of weekly nab-paclitaxel with or without bevacizumab and dose dense doxorubicin and cyclophophamide
TIS in PD-1 and CTLA-4 treated melanomas